Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	98.09	159.52	137.55	91.39	63.3
Depreciation & Amortization	56.7	52.97	38.04	24.77	23.27
Stock-Based Compensation	27.28	24.37	20.24	17.86	18.69
Other Adjustments	40.02	-8.92	11.89	-12.66	-5.31
Change in Receivables	-6.37	-21.67	-26.09	-10.13	-14.92
Changes in Inventories	-21.06	-48.8	-1.72	-11.75	1.26
Changes in Accounts Payable	-4.56	63.56	13.24	-0.74	3.63
Changes in Income Taxes Payable	-24.84	6.83	-3.32	-4.56	8.35
Changes in Other Operating Activities	-9.14	-14.48	-6.32	-5.01	-0.27
Operating Cash Flow	156.12	213.39	183.5	89.18	97.99
Operating Cash Flow Growth	-26.84%	16.29%	105.77%	-8.99%	71.12%
Capital Expenditures	-34.88	-41.04	-38.17	-24.03	-27.46
Sale of Property, Plant & Equipment	-	-	-	0.42	-
Purchases of Intangible Assets	-2.25	-	-	-	-
Purchases of Investments	-119.13	-76.79	-144.56	-35.76	-17.38
Proceeds from Sale of Investments	90.29	126.02	38.62	27.97	18.77
Payments for Business Acquisitions	-	-129	-506.41	-	-
Other Investing Activities	-4.36	-4.12	1.39	-1.37	-2.61
Investing Cash Flow	-70.33	-124.93	-649.12	-32.78	-28.67
Short-Term Debt Issued	6.22	18.43	-	-	-
Short-Term Debt Repaid	-	-	-	-	-1.16
Net Short-Term Debt Issued (Repaid)	6.22	18.43	-	-	-1.16
Long-Term Debt Issued	-	-	845	-	70
Long-Term Debt Repaid	-0.22	-8.26	-318.66	-1.78	-36.74
Net Long-Term Debt Issued (Repaid)	-0.22	-8.26	526.34	-1.78	33.26
Issuance of Common Stock	2.86	-4.85	10.97	15.66	15.93
Repurchase of Common Stock	-75.59	-85.46	-58.14	-39.91	-28.87
Net Common Stock Issued (Repurchased)	-72.73	-90.31	-47.17	-24.25	-12.95
Other Financing Activities	-0.69	-0.82	-25.08	-0.41	-56.17
Financing Cash Flow	-67.43	-80.95	454.09	-26.44	-37.02
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.21	-0.19	-0.28	-0.22	-0.22
Net Cash Flow	18.57	7.31	-11.8	29.75	32.08
Free Cash Flow	121.23	172.35	145.34	65.15	70.54
Free Cash Flow Growth	-29.66%	18.58%	123.09%	-7.64%	201.30%
FCF Margin	16.84%	23.55%	22.55%	13.06%	16.11%
Free Cash Flow Per Share	2.51	3.31	2.74	1.24	1.42
Levered Free Cash Flow	66.3	188.74	665.63	68.3	105.37
Unlevered Free Cash Flow	73.62	192.35	162.14	64.44	61.53

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q